162 related articles for article (PubMed ID: 38402182)
1. Emerging trends in the coexistence of primary lung Cancer and hematologic malignancy: a comprehensive analysis of clinicopathological features and genetic abnormalities.
Lyu M; Luo L; Zhou L; Feng X; Yang J; Xu Z; Sun X; Bao Z; Wang X; Gao B; Xiang Y
Cancer Cell Int; 2024 Feb; 24(1):84. PubMed ID: 38402182
[TBL] [Abstract][Full Text] [Related]
2. Genomic and clinicopathological features of lung adenocarcinomas with micropapillary component.
Li P; Liu L; Wang D; Yang R; Xuan Y; Han Y; Wang J; Guo L; Zhang L; Zhang S; Wang Y
Front Oncol; 2022; 12():989349. PubMed ID: 36457500
[TBL] [Abstract][Full Text] [Related]
3. Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(24):1-48. PubMed ID: 23074402
[TBL] [Abstract][Full Text] [Related]
4. Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer.
Kim C; Chon H; Kang B; Kim K; Jeung HC; Chung H; Noh S; Rha S
BMC Cancer; 2013 Aug; 13():394. PubMed ID: 23967865
[TBL] [Abstract][Full Text] [Related]
5. Survival analysis of patients with advanced non-small cell lung cancer receiving EGFR-TKI treatment of Yunnan in southwestern China: a real-world study.
Lin Y; Chen L; Li R; Liu X; Li Q; Cai J; Du Y; Zhao G; Wang X; Shen Z; Liao Y; Chen Y; Xie L; Zhou Y; Huang Y
Front Oncol; 2023; 13():1156647. PubMed ID: 37881485
[TBL] [Abstract][Full Text] [Related]
6. [Clinical analysis of 121 cases of urothelial carcinoma accompanied with multiple primary carcinoma].
Gu YC; Ye JF; Cao BS; Wang MP; Ma LL; Ma LW
Zhonghua Zhong Liu Za Zhi; 2019 Oct; 41(10):760-764. PubMed ID: 31648498
[No Abstract] [Full Text] [Related]
7. A high number of co-occurring genomic alterations detected by NGS is associated with worse clinical outcomes in advanced EGFR-mutant lung adenocarcinoma: Data from LATAM population.
Heredia D; Mas L; Cardona AF; Oyervides V; Motta Guerrero R; Galvez-Nino M; Lara-Mejía L; Aliaga-Macha C; Carracedo C; Varela-Santoyo E; Ramos-Ramírez M; Davila-Dupont D; Martínez J; Cruz-Rico G; Remon J; Arrieta O
Lung Cancer; 2022 Dec; 174():133-140. PubMed ID: 36379126
[TBL] [Abstract][Full Text] [Related]
8. A clinical and radiologic study of primary liver cancer associated with extrahepatic primary cancer.
Takayasu K; Kasugai H; Ikeya S; Muramatsu Y; Moriyama N; Makuuchi M; Yamazaki S; Hirohashi S
Cancer; 1992 Jan; 69(1):45-51. PubMed ID: 1309309
[TBL] [Abstract][Full Text] [Related]
9. [Differences in clinicopathological features, gene mutations, and prognosis between primary gastric and intestinal gastrointestinal stromal tumors in 1061 patients].
Li JX; Sun L; Zhao S; Shao B; Guo YH; Chen S; Liang H; Sun Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Apr; 26(4):346-356. PubMed ID: 37072312
[No Abstract] [Full Text] [Related]
10. A comprehensive investigation of molecular features and prognosis of lung adenocarcinoma with micropapillary component.
Zhang Y; Wang R; Cai D; Li Y; Pan Y; Hu H; Wang L; Li H; Ye T; Luo X; Zhang Y; Li B; Shen L; Sun Y; Chen H
J Thorac Oncol; 2014 Dec; 9(12):1772-8. PubMed ID: 25226429
[TBL] [Abstract][Full Text] [Related]
11. [The efficacy and prognostic factors of immunotherapy in advanced non-small cell lung cancer patients with different driver gene mutations].
Ma SX; Ma N; Han J; He Z; Wang L; Wang Q
Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(13):922-929. PubMed ID: 35385963
[No Abstract] [Full Text] [Related]
12. Clinicopathologic features of metachronous or synchronous gastric cancer patients with three or more primary sites.
Kim JH; Rha SY; Kim C; Kim GM; Yoon SH; Kim KH; Kim MJ; Ahn JB; Chung HC; Roh JK; Kim HS
Cancer Res Treat; 2010 Dec; 42(4):217-24. PubMed ID: 21253324
[TBL] [Abstract][Full Text] [Related]
13. MET overexpression in EGFR L858R mutant treatment-naïve advanced lung adenocarcinoma correlated with poor prognosis: a real-world retrospective study.
Wang N; Zhu Y; Wu Y; Huang B; Wu J; Zhang R; Fan J; Nie X
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3219-3228. PubMed ID: 35904603
[TBL] [Abstract][Full Text] [Related]
14. The Prognosis of Advanced Non-Small Cell Lung Cancer Patients with Precision-Targeted Therapy Guided by NGS Testing or Routine Testing.
Tu T; Chen D; Jiang H; Ma J; Wang H; Chen C
Cancer Manag Res; 2023; 15():1307-1318. PubMed ID: 38027245
[TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of multiple primary cancers associated with bladder cancer].
Takahashi S; Sugimoto M; Shinohara M; Kinoshita K
Nihon Hinyokika Gakkai Zasshi; 1992 Jul; 83(7):1118-23. PubMed ID: 1507729
[TBL] [Abstract][Full Text] [Related]
16. [Trend analysis and clinicopathological characteristics of 198 young patients with advanced lung adenocarcinoma].
Li YF; Wang Y; Li JL; Hao XZ; Hu XS; Wang HY
Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):750-755. PubMed ID: 27784458
[No Abstract] [Full Text] [Related]
17. Multiple primary cancers involving lung cancer at a single tertiary hospital: Clinical features and prognosis.
Kim SW; Kong KA; Kim DY; Ryu YJ; Lee JH; Chang JH
Thorac Cancer; 2015 Mar; 6(2):159-65. PubMed ID: 26273353
[TBL] [Abstract][Full Text] [Related]
18. Postoperative Management of Multiple Primary Cancers Associated with Non-small Cell Lung Cancer.
Shoji F; Yamazaki K; Miura N; Katsura M; Oku Y; Takeo S; Maehara Y
Anticancer Res; 2018 Jun; 38(6):3773-3778. PubMed ID: 29848742
[TBL] [Abstract][Full Text] [Related]
19. Driver mutation profiles and clinicopathological correlation in pulmonary adenocarcinoma with a micropapillary component.
Zhang J; Sun J; Zhang Z; Wang A; Liang X; Lu J; Liang Z
Hum Pathol; 2019 Mar; 85():242-250. PubMed ID: 30465798
[TBL] [Abstract][Full Text] [Related]
20. [Survival analysis of different kinds of tyrosine kinase inhibitors in the treatment of patients with epidermal growth factor receptor mutated non-small cell lung cancer and leptomeningeal metastasis].
Xu HY; Chen HQ; Kong JX; Zhang Y; Liu S; Yang GJ; Wang Y
Zhonghua Yi Xue Za Zhi; 2022 Feb; 102(6):399-405. PubMed ID: 35144338
[No Abstract] [Full Text] [Related]
[Next] [New Search]
